BioRePeelCl3 BODY Chemical Peel (3 x 12 ml)

BioRePeel

Professional chemical peel

Body TCA peel

CE Marked medical device under applicable EU medical device regulations (BioRePeelCl3 FND and BODY)
Manufactured by CMed Aesthetics S.p.A., an Italian medical device company operating to quality Management standards for medical devices (including ISO 13485 Compliant processes)
Intended and labelled for professional use only in accordance with local clinical governance and aesthetic practice regulations
Use must comply with national regulations for medical devices and professional scope Of Practice requirements in the country of use

CE Marked medical device under applicable EU medical device regulations (BioRePeelCl3 FND and BODY)
Manufactured by CMed Aesthetics S.p.A., an Italian medical device company operating to quality Management standards for medical devices (including ISO 13485 Compliant processes)
Intended and labelled for professional use only in accordance with local clinical governance and aesthetic practice regulations
Use must comply with national regulations for medical devices and professional scope Of Practice requirements in the country of use

Body TCA peel

Description

BioRePeelCl3 BODY Chemical Peel by CMed Aesthetics is a professional, two-phase (biphasic) topical medical device designed specifically for body skin rejuvenation. Supplied as a pack of 3 x 12 ml ampoules, the formula contains 50% trichloroacetic acid (TCA) combined with α-hydroxy acids, β-hydroxy acids, poly-hydroxy acids, amino acids, vitamins and GABA. This synergy promotes marked exfoliation of dead cells, supports collagen stimulation and cell renewal, and enhances antioxidant and moisturising effects. It is indicated for treatment of body areas such as the back, shoulders, buttocks, legs, knees, elbows, hands and feet, helping to improve uneven texture, dryness, acne, superficial scars and other aesthetic concerns. The treatment is needle-free, fast, and designed to deliver immediate multifunctional results with minimal downtime, without frost, post-treatment scarring or oxidation darkening, and can be used in all seasons when performed by trained professionals.

Bnefits

High-strength 50% TCA body peel with biostimulating, revitalising and peeling actions
Promotes marked exfoliation of dead cells and accelerates epidermal turnover
Improves body skin texture, smoothness and luminosity
Helps reduce superficial scars, post-acne marks and body acne
Addresses uneven skin tone and dryness on areas such as back, shoulders, buttocks, legs, knees, elbows, hands and feet
Provides antioxidant and moisturising effects via amino acids, vitamins and GABA
Lipophilic phase offers filming and moisturising action, supporting barrier function
Non-invasive, needle-free procedure with minimal discomfort and downtime
No frost effect and low risk of post-treatment scarring or oxidation darkening when correctly used
Does not require cold storage and can be used year-round with appropriate sun protection

Indications

Dull, rough or photoaged body skin
Uneven skin texture and superficial body scars
Mild to moderate body acne and post-acne marks
Dryness and loss of radiance on body areas such as back, shoulders, buttocks, legs, knees, elbows, hands and feet
Hyperpigmentation and dyschromia on the body within the practitioner’s clinical judgement
Adjuvant treatment in the prevention of acne and its scarring outcomes on suitable body areas
Patients seeking comprehensive body skin rejuvenation with minimal downtime and no needles

Composition

Trichloroacetic acid (TCA) 50% (primary peeling and biostimulating agent)
Lactobionic acid (poly-hydroxy acid)
Salicylic acid (beta-hydroxy acid)
Tartaric acid (alpha-hydroxy acid)
Citric acid (alpha-hydroxy acid)
Aminobutyric acid (GABA, gamma-aminobutyric acid)
Amino acids: glycine, proline, hydroxyproline, arginine
Vitamins: vitamin C (ascorbic acid), vitamin B2 (riboflavin)
Lipophilic phase components including squalene and isopropyl myristate to provide filming and moisturising action and protect the hydrophilic phase from oxidation
Excipients and stabilisers as specified in the full CMed Aesthetics formulation

Formulation

Two-phase (biphasic) topical chemical peel composed of a hydrophilic (yellow) and a lipophilic (blue) phase
High-strength 50% TCA-based body peel with a total of 14 active ingredients
Solution must be shaken vigorously before use until it becomes a homogenous green emulsion
Topical medical device for external use only, intended exclusively for professional use by trained medical and aesthetic practitioners

Packaging

Retail/professional pack containing 3 ampoules/vials of 12 ml each (3 x 12 ml)
Each 12 ml glass ampoule/vial holds the biphasic BioRePeelCl3 BODY solution
Compact pack size facilitates storage and allows practitioners to customise doses for different body areas
Professional packaging within the BioReTherapy range of CMed Aesthetics

Usage

For professional use only; treatment must be carried out by a suitably trained healthcare or aesthetic professional following official protocols.
Cleanse and degrease the treatment area according to the BioRePeelCl3 protocol (e.g. with an appropriate pre-peel cleanser or antiseptic solution).
Shake the BioRePeelCl3 BODY ampoule/vial vigorously until the two phases form a uniform green emulsion.
Using a sterile syringe, withdraw the required volume (commonly up to around 2 ml per body zone, adjusted to area size and protocol) without removing the stopper where applicable.
Apply the product evenly over the selected body area (e.g. back, shoulders, buttocks, legs, knees, elbows, hands, feet) using gloved fingers or another suitable applicator, gently massaging until the solution is well distributed.
Allow the product to act for approximately 5–10 minutes on body areas, with contact time adjusted within protocol limits according to skin type, area and practitioner judgement.
At the end of the exposure time, remove the product carefully using gauze or cotton soaked in water (or saline), ensuring all residue is removed from the skin.
Apply recommended post-treatment products from the BioReTherapy line (such as BioReHydra serum and BioReLift cream) or other suitable soothing and hydrating care as per clinic protocol.
Standard treatment course per area typically comprises 4–6 sessions, with BioRePeelCl3 BODY applied every 10–15 days, in line with the CMed Aesthetics protocol-of-use.
Instruct patients to avoid intense heat, friction and strong active skincare (such as other peels, high-strength acids or retinoids) on the treated area for several days and to use broad-spectrum sunscreen where the area may be exposed.
Always refer to and follow the latest official instructions for use (IFU) and classic protocol of CMed Aesthetics for BioRePeelCl3 BODY; do not deviate from approved guidelines.

Contraindications

Known allergy or hypersensitivity to trichloroacetic acid, salicylic acid (including aspirin intolerance), lactobionic acid, tartaric acid, citric acid, GABA, included amino acids, vitamins C or B2, or any other component of the formulation
Pregnancy and breastfeeding (commonly treated as a contraindication or strong precaution according to local clinical guidance and clinic policy)
Active bacterial, viral or fungal infections, or open wounds, cuts or abrasions in the intended treatment area
Active inflammatory dermatoses such as uncontrolled eczema, psoriasis, dermatitis or other significant irritation on the treatment zone
History of hypertrophic scars or keloid formation in the area to be treated
History of skin cancers or premalignant lesions in the treatment area unless cleared by an appropriate specialist
Uncontrolled systemic disease (e.g. poorly controlled diabetes, significant autoimmune disease) where wound healing may be impaired, according to the supervising physician’s judgement
Use of systemic isotretinoin (e.g. Roaccutane) within the previous 6–12 months, depending on current clinical guidelines and practitioner assessment
Recent aggressive aesthetic procedures on the same area (deep chemical peels, ablative laser treatments, dermabrasion, deep microneedling) without adequate recovery time
Severe photosensitivity disorders or concurrent use of medications causing marked photosensitivity without appropriate precautions
Inability or unwillingness to comply with post-treatment care instructions, including sun protection, gentle skincare and treatment spacing

Adverse Effects

Transient burning, stinging, tingling or warmth in the treated area during and shortly after application
Post-treatment erythema (redness) and mild swelling that typically resolve within hours to a few days
Dryness, tightness and varying degrees of flaking or desquamation as the exfoliated outer layers shed
Temporary increase in skin sensitivity to touch, heat, skincare products and environmental exposure
Potential purging or temporary flare of comedones and inflammatory lesions in acne-prone skin as congestion is brought to the surface
Irritation, superficial erosions or over-peeling if contact time, quantity applied or patient selection is inappropriate or if aftercare is not followed
Risk of post-inflammatory hyperpigmentation, especially in higher Fitzpatrick skin types or when photoprotection is inadequate
Very rare but possible complications such as infection, scarring or persistent pigmentary changes if contraindications are ignored, technique is poor or if the patient fails to follow aftercare advice

Storage Conditions

Store at controlled room temperature as indicated on the product packaging, away from direct sunlight and sources of heat.
Cold storage is not required; however, the product should be protected from extreme temperatures and sudden temperature changes.
Keep ampoules/vials in their original outer carton to protect from light and to reduce the risk of contamination or damage.
Ensure ampoules/vials are intact and the solution appears normal; do not use if packaging is damaged, if unusual instability is observed after shaking, or if the product is past its expiry date.
Follow local regulations and CMed Aesthetics guidance for the safe storage and disposal of chemical peel medical devices.

Duration

Typically performed as a course of 4\u20136 sessions on each treated body area, with BioRePeelCl3 BODY applications repeated every 10\u201315 days according to the official protocol. Product contact time per session on body areas is usually around 5\u201310 minutes, with overall appointment time (including preparation and post-care) averaging 30\u201340 minutes.

Onset

Most patients experience an immediate feeling of smoother, refreshed skin after the first session, with visible improvements in texture, radiance and superficial imperfections often apparent within the first few treatments. Optimal aesthetic results typically develop progressively over the full course of 4\u20136 sessions and continue to consolidate over subsequent weeks due to ongoing cell renewal and dermal remodelling.